The Capital Mind Monsoon Portfolio At the start of the monsoons we have created the CM-Monsoon portfolio. The portfolio consists of the stocks which have ...
This time we took the volatility on the Brexit day to get a trade that made us a decent profit. Even though the market rebounded nearly 300 points, we ...
The Slack Discussions The Slack group at Capital Mind Premium has been extremely active and if you haven’t been there (Premium subscribers only), pop us a ...
Economic Times carried an article yesterday which took DLF shares up nearly 8%, because, goodness the promoter was going to pump in 10,000 cr. into the company ...
Capitalmind speaks of a new way to allocate a lumpsum cash amount and recover interest from it, every month and pay 80% less tax compared to a Fixed ...
As a follow-up note on MCLR (Marginal Cost of funds based Lending Rate) and how it is changing the way banks lend in India, we are publishing the rates of ...
The consumer are facing the bitter price of sugar, but the investors are enjoying the flavor of the sweet commodity. When the market was grappling with ...
Shilpa Medicare deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides / Biotech ...
Yes. Remember this that UK on its own, represents 2.5% of the world pharmaceutical market (the market is over $1 trillion) and the market has not grown to this ...
Foreign Portfolio Investors (FPIs) have, in a strange way, sold a lot of debt, while continuing to buy equity. In June, while they sold a bit through the last ...
